Drug Pipeline

Lumason Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
6
Recruiting
1
Phase 3
7
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Phase 1
2
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06400004 Lumason® Infusion vs. Bolus Administrations Heart Diseases Recruiting
Phase 2
NCT05641935 Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC)… Recurrent Renal Cell Carcinoma Recruiting
NCT06261814 Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With… Liver Neoplasms Recruiting
Phase 1/2
NCT06329570 Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment… Glioblastoma Multiforme Recruiting
Phase 1
NCT06171607 Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses Breast Carcinoma Recruiting
NCT06600880 Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its… Alzheimer Disease, Early Onset Not Yet Recruiting
Early Phase 1
NCT03107520 Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of… Developmental Dysplasia of the Hip Recruiting
Not specified
NCT07274787 Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma GBM Not Yet Recruiting
Sponsors Running Lumason Trials
Disease Areas
Get alerts when Lumason trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free